These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17010802

  • 1. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1399-404. PubMed ID: 17010802
    [Abstract] [Full Text] [Related]

  • 2. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2006 May 02; 47(9):1820-7. PubMed ID: 16682307
    [Abstract] [Full Text] [Related]

  • 3. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS, Bartone C, Booth T, Kereiakes D, Chow T.
    Am Heart J; 2007 Apr 02; 153(4):523-9. PubMed ID: 17383288
    [Abstract] [Full Text] [Related]

  • 4. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):456-63. PubMed ID: 16412877
    [Abstract] [Full Text] [Related]

  • 5. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L, Szwoch M, Kempa M, Raczak G.
    Kardiol Pol; 2012 Jan 17; 70(8):795-802. PubMed ID: 22933211
    [Abstract] [Full Text] [Related]

  • 6. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
    Baravelli M, Fantoni C, Rogiani S, Farina S, Anzà C, Caltabiano V, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2007 Sep 14; 121(1):23-9. PubMed ID: 17188766
    [Abstract] [Full Text] [Related]

  • 7. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2005 Oct 20; 105(1):53-7. PubMed ID: 16207545
    [Abstract] [Full Text] [Related]

  • 8. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R, Michałkiewicz D, Cholewa M, Jacewicz K, Gniłka A, Adamus J.
    Pol Merkur Lekarski; 2006 Oct 20; 21(124):310-3. PubMed ID: 17205766
    [Abstract] [Full Text] [Related]

  • 9. How to do exercise-induced T-wave alternans testing using the spectral method.
    Klingenheben T, Ptaszyński P.
    Cardiol J; 2008 Oct 20; 15(3):288-92. PubMed ID: 18651425
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, Kasamaki Y, Yoshida A, Kato T.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2268-74. PubMed ID: 17161258
    [Abstract] [Full Text] [Related]

  • 11. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG, MASTER Trial Investigators.
    J Am Coll Cardiol; 2008 Nov 11; 52(20):1607-15. PubMed ID: 18992649
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ, Stein KM, Markowitz SM, Mittal S, Shah BK, Morin DP, Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S.
    J Am Coll Cardiol; 2007 Jul 10; 50(2):166-73. PubMed ID: 17616302
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P, Guo T, Tang YM, Zhao L, Li SM, Liu ZM.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun 10; 36(6):517-22. PubMed ID: 19100065
    [Abstract] [Full Text] [Related]

  • 14. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure.
    Jackson CE, Myles RC, Tsorlalis IK, Dalzell JR, Spooner RJ, Rodgers JR, Bezlyak V, Greenlaw N, Ford I, Cobbe SM, Petrie MC, McMurray JJ.
    Eur J Heart Fail; 2012 Apr 10; 14(4):377-86. PubMed ID: 22334727
    [Abstract] [Full Text] [Related]

  • 15. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT.
    Circulation; 2004 Oct 05; 110(14):1885-9. PubMed ID: 15451804
    [Abstract] [Full Text] [Related]

  • 16. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):50-8. PubMed ID: 17207722
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.
    Am J Cardiol; 2007 Aug 15; 100(4):598-604. PubMed ID: 17697813
    [Abstract] [Full Text] [Related]

  • 18. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators.
    J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.